Is Cencora Stock Outperforming the S&P 500?

With a market cap of $69.9 billion, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a global pharmaceutical sourcing and distribution company. The company provides a wide range of healthcare products, logistics, and commercialization services to pharmacies, hospitals, biotechnology and pharmaceutical manufacturers, and other healthcare providers. 

Companies valued at $10 billion or more are generally considered “large-cap” stocks, and Cencora fits this criterion perfectly. Operating through the U.S. Healthcare Solutions and International Healthcare Solutions segments, Cencora distributes pharmaceuticals, vaccines, medical supplies, and related services across the United States and internationally.